Back to top
more

Aurora Cannabis (ACB)

(Delayed Data from NSDQ)

$6.24 USD

6.24
2,590,496

+0.49 (8.43%)

Updated Jul 22, 2024 03:59 PM ET

After-Market: $6.24 +0.01 (0.08%) 4:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth B Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 250)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for ACB

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Aurora Cannabis Inc falls in the month of March.

All items in Millions except Per Share data.

3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Assets          
Cash & Equivalents 136 -99,999 387 347 126
Receivables 34 NA 37 44 40
Notes Receivable 0 NA 0 0 0
Inventories 138 NA 111 108 117
Other Current Assets 9 NA 54 21 30
Total Current Assets 316 NA 589 520 314
Net Property & Equipment 218 NA 184 473 706
Investments & Advances 0 NA 1 0 14
Other Non-Current Assets 5 NA 4 11 3
Deferred Charges 11 NA 0 0 0
Intangibles 62 NA 56 980 1,000
Deposits & Other Assets 9 NA 23 49 40
Total Assets 622 NA 857 2,033 2,076
Liabilities & Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Notes Payable 0 NA 0 0 0
Accounts Payable 43 NA 55 45 71
Current Portion Long-Term Debt 39 NA 21 27 114
Current Portion Capital Leases 4 NA 5 5 0
Accrued Expenses 0 NA 0 0 0
Income Taxes Payable 1 NA 0 0 0
Other Current Liabilities 5 NA 33 14 18
Total Current Liabilities 92 NA 115 91 203
Mortgages 0 NA 0 0 0
Deferred Taxes/Income 12 NA 2 3 3
Convertible Debt 0 NA 158 229 220
Long-Term Debt 4 NA 0 43 62
Non-Current Capital Leases 32 NA 29 51 0
Other Non-Current Liabilities 36 NA 30 72 1
Minority Interest (Liabilities) 0 NA 0 0 0
Total Liabilities 176 NA 333 443 490
Shareholders Equity 3/31/2024 3/31/2023 3/31/2022 3/31/2021 3/31/2020
Preferred Stock 0 NA 0 0 0
Common Stock (Par) 5,168 NA 5,337 5,015 4,314
Capital Surplus 0 NA 0 0 0
Retained Earnings -4,721 NA -4,771 -3,373 -2,679
Other Equity -1 NA -43 -51 -49
Treasury Stock 0 NA 0 0 0
Total Shareholder's Equity 446 NA 523 1,591 1,585
Total Liabilities & Shareholder's Equity 622 NA 857 2,033 2,076
Total Common Equity 446 0 523 1,591 1,585
Shares Outstanding 54.50 35.10 22.40 19.80 10.10
Book Value Per Share 8.19 0.00 23.36 80.33 156.98

Fiscal Year End for Aurora Cannabis Inc falls in the month of March.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 136 154 144 -99,833
Receivables NA 34 32 30 24
Notes Receivable NA 0 0 0 NA
Inventories NA 138 106 104 93
Other Current Assets NA 9 7 12 14
Total Current Assets NA 316 299 289 297
Net Property & Equipment NA 218 217 229 229
Investments & Advances NA 0 0 0 NA
Other Non-Current Assets NA 5 5 6 6
Deferred Charges NA 11 11 11 11
Intangibles NA 62 58 59 58
Deposits & Other Assets NA 9 10 16 17
Total Assets NA 622 600 610 619
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 NA
Accounts Payable NA 43 46 38 46
Current Portion Long-Term Debt NA 39 15 31 55
Current Portion Capital Leases NA 4 4 4 4
Accrued Expenses NA 0 0 0 NA
Income Taxes Payable NA 1 0 0 0
Other Current Liabilities NA 5 15 15 22
Total Current Liabilities NA 92 79 88 128
Mortgages NA 0 0 0 NA
Deferred Taxes/Income NA 12 12 12 12
Convertible Debt NA 0 0 0 NA
Long-Term Debt NA 4 26 26 26
Non-Current Capital Leases NA 32 32 34 31
Other Non-Current Liabilities NA 42 41 44
Minority Interest (Liabilities) NA 0 0 0 NA
Total Liabilities NA 176 190 201 241
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 NA
Common Stock (Par) NA 5,168 5,096 5,142 5,100
Capital Surplus NA 0 0 0 NA
Retained Earnings NA -4,721 -4,677 -4,726 -4,705
Other Equity NA -1 -9 -6 -17
Treasury Stock NA 0 0 0 NA
Total Shareholder's Equity NA 446 410 409 378
Total Liabilities & Shareholder's Equity NA 622 600 610 619
Total Common Equity 0 446 410 409 100,377
Shares Outstanding 54.50 54.50 47.50 47.30 37.60
Book Value Per Share 0.00 8.19 8.63 8.65 2,669.60